Clinical Trial Update: Evaluating Newly Approved Drugs in Combination Regimens for Multidrug-Resistant TB With Fluoroquinolone Resistance (endTB-Q) [Phase 3]

View source ↗

Summary

Phase 3 endTB-Q trial evaluating regimens with newly approved drugs for multidrug-resistant tuberculosis with fluoroquinolone resistance has completed. This upd…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis
• Tuberculosis Multidrug-resistant

Drugs mentioned

• Pretomanid (pretomanid)
• SIRTURO (bedaquiline fumarate)
• ZYVOX (LINEZOLID)

Snippet

Sponsor: Médecins Sans Frontières, France | Conditions: Tuberculosis, Multidrug-Resistant, Tuberculosis | Phase 3 | Status: COMPLETED